News Home

Is Aerie Pharmaceuticals Inc (AERI) a Good Choice in Drug Manufacturers - Specialty & Generic Monday?

Monday, October 03, 2022 03:39 PM | InvestorsObserver Analysts
Is Aerie Pharmaceuticals Inc (AERI) a Good Choice in Drug Manufacturers - Specialty & Generic Monday?

Aerie Pharmaceuticals Inc (AERI) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. AERI received an overall rating of 67, which means that it scores higher than 67 percent of all stocks. Aerie Pharmaceuticals Inc also achieved a score of 93 in the Drug Manufacturers - Specialty & Generic industry, putting it above 93 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 139 out of the 148 industries.

Overall Score - 67
AERI has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on AERI!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Aerie Pharmaceuticals Inc Stock Today?

Aerie Pharmaceuticals Inc (AERI) stock is lower by -0.23% while the S&P 500 has gained 2.89% as of 3:37 PM on Monday, Oct 3. AERI has fallen -$0.03 from the previous closing price of $15.13 on volume of 1,503,411 shares. Over the past year the S&P 500 has fallen -14.21% while AERI has gained 33.16%. AERI lost -$1.04 per share the over the last 12 months. Click Here to get the full Stock Report for Aerie Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App